Latest Market News
UK at Crossroads: Energy Crisis and Weight-Loss Drug Boom
As UK faces surging fuel demand and a potential obesity drug revolution, the nation's economic priorities are tested.
Denmark Poised as Next Launchpad for Wegovy Pill
Novo Nordisk eyes Denmark, UK, and Germany for Wegovy pill launch, targeting global weight loss market beyond US dominance.
Novo Nordisk Lifts 2026 Guidance on Wegovy Sales Surge
Novo Nordisk raises 2026 outlook as Wegovy captures 65% of new US prescriptions, while Pandora faces tariff and silver price pressures.